FDA Warning Letter — Harbin Jixianglong Biotech Co., Ltd.
The FDA took a Warning Letter action against Harbin Jixianglong Biotech Co., Ltd. on May 1, 2026 (Haerbin, China). The action was issued by CDER and concerns drugs products. This facility has 1 recent FDA inspection on record.
Action Details
- Facility
- Harbin Jixianglong Biotech Co., Ltd.
- Date
- May 1, 2026
- Fiscal Year
- 2026
- Product Type
- Drugs
- Center
- CDER
- Location
- Haerbin (China)